Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
Mehta
B C
BC
Hematology Department, Seth GS Medical College and KEM Hospital, Mumbai.
D000284:Administration, Oral; D018798:Anemia, Iron-Deficiency / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D005290:Ferric Compounds / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005296:Ferrous Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D006397:Hematinics / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007049:Iatrogenic Disease; D008875:Middle Aged; D013997:Time Factors
D005290:Ferric Compounds; D005296:Ferrous Compounds; D006397:Hematinics